Skip to main content
Print Save

WPI 2281 (Zolpidem Tartrate Extended-Release 6.25 mg)

Pill with imprint WPI 2281 is Green, Round and has been identified as Zolpidem Tartrate Extended-Release 6.25 mg. It is supplied by Watson Laboratories, Inc.

Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 6.25 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 2281

Zolpidem Tartrate Extended-Release

Imprint
WPI 2281
Strength
6.25 mg
Color
Green
Shape
Round
Availability
Prescription only
Drug Class
Miscellaneous anxiolytics, sedatives and hypnotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-2281
Inactive Ingredients
lactose anhydrous, silicon dioxide, dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer, FD&C Blue No. 1, FD&C Blue No. 2, hydroxypropyl cellulose, hypromelloses, ferrosoferric oxide, ferric oxide yellow, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, microcrystalline cellulose, polyethylene glycol, propylene glycol, sodium bicarbonate, sodium lauryl sulfate, magnesium silicate, titanium dioxide, triethyl citrate, polysorbate 80

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer